Product
HR18034;Ropivacaine Hydrochloride
1 clinical trial
1 indication
Indication
Knee ReplacementClinical trial
A Phase Ⅱ Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Single Injection Adductor Canal Block With HR18034 for Postoperative Pain ManagementStatus: Active (not recruiting), Estimated PCD: 2024-12-01